ProfileGDS4718 / 233298_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 22% 17% 24% 13% 12% 17% 33% 21% 26% 16% 12% 14% 18% 11% 33% 23% 17% 11% 4% 28% 21% 20% 29% 19% 18% 18% 9% 18% 11% 16% 20% 20% 22% 11% 24% 21% 30% 22% 32% 21% 17% 10% 7% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.255923
GSM549102patient 115, normal, homogenized [OPG study]4.2526822
GSM549104patient 119, normal, homogenized [OPG study]4.0078717
GSM549108patient 138, normal, homogenized [OPG study]4.3492624
GSM549119patient 077, normal, homogenized [OPG study]3.9096613
GSM549133patient 032, cancer, homogenized [OPG study]3.7964112
GSM549139patient 042, cancer, homogenized [OPG study]4.0163517
GSM549099patient 107, normal, homogenized [OPG study]4.683633
GSM549109patient 139, normal, homogenized [OPG study]4.2139121
GSM549110patient 046, normal, homogenized [OPG study]4.372126
GSM549114patient 063, normal, homogenized [OPG study]3.9811316
GSM549122patient 082, normal, homogenized [OPG study]3.8529212
GSM549134patient 033, cancer, homogenized [OPG study]3.9280514
GSM549136patient 036, cancer, homogenized [OPG study]4.0219918
GSM549140patient 044, cancer, homogenized [OPG study]3.7790711
GSM549111patient 047, normal, homogenized [OPG study]4.6613233
GSM549113patient 057, normal, homogenized [OPG study]4.1974923
GSM549132patient 031, cancer, homogenized [OPG study]4.0130217
GSM549137patient 038, cancer, homogenized [OPG study]3.8090811
GSM549142patient 047, cancer, homogenized [OPG study]3.56454
GSM549100patient 110, normal, homogenized [OPG study]4.4584128
GSM549107patient 135, normal, homogenized [OPG study]4.1404721
GSM549115patient 068, normal, homogenized [OPG study]4.0902320
GSM549116patient 072, normal, homogenized [OPG study]4.4962229
GSM549120patient 078, normal, homogenized [OPG study]4.1106419
GSM549131patient 030, cancer, homogenized [OPG study]4.0322318
GSM549118patient 074, normal, homogenized [OPG study]4.0677118
GSM549129patient 027, cancer, homogenized [OPG study]3.746239
GSM549123patient 088, normal, homogenized [OPG study]4.0614618
GSM549124patient 006, cancer, homogenized [OPG study]3.8501911
GSM549126patient 015, cancer, homogenized [OPG study]3.986716
GSM549128patient 025, cancer, homogenized [OPG study]4.1030520
GSM549103patient 117, normal, homogenized [OPG study]4.1735220
GSM549117patient 073, normal, homogenized [OPG study]4.2090122
GSM549138patient 041, cancer, homogenized [OPG study]3.8026111
GSM549141patient 045, cancer, homogenized [OPG study]4.2299724
GSM549130patient 028, cancer, homogenized [OPG study]4.1904321
GSM549101patient 111, normal, homogenized [OPG study]4.571330
GSM549105patient 128, normal, homogenized [OPG study]4.2445822
GSM549106patient 134, normal, homogenized [OPG study]4.5737832
GSM549112patient 048, normal, homogenized [OPG study]4.1669621
GSM549125patient 011, cancer, homogenized [OPG study]4.0552617
GSM549127patient 024, cancer, homogenized [OPG study]3.7706410
GSM549135patient 035, cancer, homogenized [OPG study]3.617577